PAPER Egnaczyk GF, Greis KD, Stimson ER, Maggio JE

Photoaffinity cross-linking of Alzheimer's disease amyloid fibrils reveals interstrand contact regions between assembled beta-amyloid peptide subunits.

Biochemistry. 2001 Oct 2;40(39):11706-14. PubMed.

PAPER Kheterpal I, Williams A, Murphy C, Bledsoe B, Wetzel R

Structural features of the Abeta amyloid fibril elucidated by limited proteolysis.

Biochemistry. 2001 Oct 2;40(39):11757-67. PubMed.

PAPER Schacter DL, Dodson CS

Misattribution, false recognition and the sins of memory.

Philos Trans R Soc Lond B Biol Sci. 2001 Sep 29;356(1413):1385-93. PubMed.

PAPER Morris RG

Episodic-like memory in animals: psychological criteria, neural mechanisms and the value of episodic-like tasks to investigate animal models of neurodegenerative disease.

Philos Trans R Soc Lond B Biol Sci. 2001 Sep 29;356(1413):1453-65. PubMed.

PAPER Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL

Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy.

Neurology. 2001 Sep 25;57(6):952-6. PubMed.

PAPER Schupf N, Kapell D, Nightingale B, Lee JH, Mohlenhoff J, Bewley S, Ottman R, Mayeux R

Specificity of the fivefold increase in AD in mothers of adults with Down syndrome.

Neurology. 2001 Sep 25;57(6):979-84. PubMed.

PAPER Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, Dekosky ST, Ganguli M

Incidence of Alzheimer's disease in a rural community in India: the Indo-US study.

Neurology. 2001 Sep 25;57(6):985-9. PubMed.

PAPER Simons M, Keller P, Dichgans J, Schulz JB

Cholesterol and Alzheimer's disease: is there a link?

Neurology. 2001 Sep 25;57(6):1089-93. PubMed.

PAPER Bozzali M, Franceschi M, Falini A, Pontesilli S, Cercignani M, Magnani G, Scotti G, Comi G, Filippi M

Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI.

Neurology. 2001 Sep 25;57(6):1135-7. PubMed.

PAPER Wilkinson D, Murray J

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease.

Int J Geriatr Psychiatry. 2001 Sep;16(9):852-7. PubMed.

PAPER Eustace A, Kidd N, Greene E, Fallon C, Bhrain SN, Cunningham C, Coen R, Walsh JB, Coakley D, Lawlor BA

Verbal aggression in Alzheimer's disease. Clinical, functional and neuropsychological correlates.

Int J Geriatr Psychiatry. 2001 Sep;16(9):858-61. PubMed.

PAPER Tractenberg RE, Gamst A, Weiner MF, Koss E, Thomas RG, Teri L, Thal L

Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease.

Int J Geriatr Psychiatry. 2001 Sep;16(9):886-91. PubMed.

PAPER Caligiuri MP, Peavy G, Galasko DR

Extrapyramidal signs and cognitive abilities in Alzheimer's disease.

Int J Geriatr Psychiatry. 2001 Sep;16(9):907-11. PubMed.

PAPER Shanks MF, Pestell SJ, Venneri A, Taylor L, Porter RW

Anthropometric risk factors in Alzheimer's disease.

Int J Geriatr Psychiatry. 2001 Sep;16(9):918-9. PubMed.

PAPER Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12245-50. Epub 2001 Sep 25 PubMed.